Abstract
Hypertensive disorders of pregnancy (HDP) as a group of medical complications in pregnancy are believed to be associated with an increased risk of poor fetal growth, but the influence on offspring’s body composition is not clear. The aim of the present study was to evaluate the association between maternal hypertensive disorders of pregnancy and overweight status in the offspring of mothers with gestational diabetes mellitus (GDM).
A cross-sectional study among 1263 GDM mother-child pairs was performed in Tianjin, China. General linear models and logistic regression models were used to assess the associations of maternal hypertension in pregnancy with anthropometry and overweight status in the offspring from birth to 1–5 years old.
Offspring of GDM mothers who were diagnosed with hypertensive disorders during pregnancy had higher mean values of Z scores for birth weight for gestational age and birth weight for length, and higher mean values of Z scores for weight for age, weight for length/height, and body mass index for age at 1–5 years old than those of GDM mothers with normal blood pressure during pregnancy. Maternal hypertensive disorders of pregnancy were associated with increased risks of large for gestational age (OR 1.74, 95%CI 1.08–2.79) and macrosomia (OR 2.02, 95%CI 1.23–3.31) at birth and childhood overweight/obesity at 1–5 years old age (OR 1.88, 95%CI 1.16–3.04).
For offspring of mothers with GDM, maternal hypertension during pregnancy was a risk factor for macrosomia at birth and childhood overweight and obesity, and controlling the maternal hypertension may be more important for preventing large for gestational age babies and childhood obesity.
Introduction
Hypertensive disorders of pregnancy as a group of medical complications in pregnancy remain to be a major cause of maternal and infant morbidity and mortality worldwide.1 Several studies have indicated that offspring of women with hypertensive disorders of pregnancy are at increased risk for cardiovascular disease at early adults.2, 3 Other studies have found that maternal hypertensive disorders of pregnancy predict large offspring size at birth and increase the risk of cardio metabolic diseases in the offspring during childhood and adolescence.3, 4 A retrospective cohort study of 16,936 births found that maternal preeclampsia increased the risk of intrauterine growth restriction and low birth weight,5 which in turn is reported to predispose to central obesity, hypertension, coronary heart disease and insulin resistance.6, 7 Another 20-year prospective follow-up birth cohort study found that young adult offspring of maternal hypertensive pregnancies were more likely to be obese or overweight.3 However, most of the studies were focused on the association of hypertensive disorders of pregnancy with fetal growth or offspring cardiovascular disease status in young adults, few studies have assessed the relationship between hypertensive disorders of pregnancy and childhood overweight status at early young years, especially less than 5 years old.
Gestational diabetes mellitus (GDM), defined as glucose intolerance with onset or first recognition during pregnancy, 8 is one of the most common complications in pregnancy affecting 2–10% of the pregnancies in the US.9 In urban china, the prevalence of GDM has increased from 2.3% in 1999 to 8.1% in 2010.10, 11 Some studies have found that offspring of mothers exposed to GDM are at increased risk of neonatal adiposity and childhood obesity,12 and women with GDM are associated with an increased risk of hypertensive disorders of pregnancy.13 Our objective was to evaluate the association between maternal hypertensive disorders of pregnancy and overweight status in the offspring of GDM mothers.
Methods
Tianjin GDM screening project
Tianjin is the fourth largest city of China with over 13 million residents in 16 country-level administrative areas.14 About 4.3 million people live in six central urban districts. Since 1999, all pregnant women who live in six urban districts have participated in the universal screening for GDM. The average proportion of screened pregnancies was over 91% during 1999–2008.11 Following the WHO’s GDM diagnosis criteria, all pregnant women at 26–30 gestational weeks participated in a 1-hour oral glucose tolerance test (OGTT) with 50-g glucose load. 15 Women who had a glucose reading ≥7.8 mmol/l were invited to undergo a 2-hour OGTT with a 75-g glucose load at the Tianjin Women’s and Children’s Health Center. 15 All women confirming either diabetes (fasting glucose ≥7 mmol/l or 2-hour glucose ≥11.1mmol/l) or impaired glucose tolerance (IGT) (2-hour glucose ≥7.8 and <11.1 mmol/l) were regarded as having GDM.15
Study samples
A total of 4644 pregnant women diagnosed with GDM between 2005 and 2009 in six urban districts were eligible for the Tianjin Gestational Diabetes Mellitus Prevention Program (TGDMPP),15 and 1263 GDM women and their children (participation rate=27%) had completed the baseline survey for the TGDMPP from August 2009 to July 2011.14, 16–18 A total of 1263 women with GDM had fasting and 2 h glucose measured at 26–30 weeks ’gestation, and 1108 women measured HbA1c at 26–30 gestational weeks because HbA1c measurements were available from 2006. There were no differences in the OGTT at 26–30 weeks’ gestation with regard to age (28.9 vs. 28.7 years), fasting glucose (5.34 vs. 5.34 mmol/L), 2-h glucose (9.23 vs. 9.16 mmol/L), and the prevalence of IGT (90.9% vs. 91.8%) and diabetes (9.1% vs. 8.2%) between the participated and not participated women with GDM. 11 The study was approved by the Human Subjects Committee of the Tianjin Women’s and Children’s Health Center. Informed consent was obtained from each participant.
Examinations
At the baseline survey, all GDM mothers and their children completed a self-administered questionnaire and underwent a physical examination that included anthropometric and blood pressure measurements. 11 The questionnaire and measurements were collected and checked by health workers from the Tianjin Women’s and Children’s Health Center, who were intensively trained in meetings and in practical sessions. The mothers’ questionnaire included questions on the mothers’ socio-demographics (age, marital status, education, income, and occupation), history of GDM, family history of chronic diseases, medical history (hypertension, pregnancy-induced hypertension, diabetes, and hypercholesterolemia), pregnancy outcomes (prepregnancy weight, weight gain during pregnancy, and number of children), dietary habits (a self-administered food frequency questionnaire to measure the frequency and quantity of intake of 33 major food groups and beverages during the past year),19 alcohol intake, smoking habits, passive smoking, and physical activity (the frequency and duration of leisure time and sedentary activities) .16–18 Women who reported doctors-diagnosed hypertension after 20 weeks (including gestational hypertension, preeclampsia, severe preeclampsia, or eclampsia) of gestation on the questionnaire were classified as having a history of hypertensive disorders of pregnancy.20 The children’s questionnaire included questions on the child’s birth date, sex, gestational weeks of birth, birth weight, birth recumbent length, and Apgar score (above questions related to birth were copied from the birth certificate), as well as the mode and duration of infant feeding (exclusive breast feeding, mixed breast and formula feeding, weaned from breast feeding, and exclusive formula feeding), health characteristics (history of illness status and current health status), dietary habits (usual habits of eating breakfast, lunch, and dinner, usual frequency of intake of vegetables, fruits, sugar-sweetened beverages, and fast food), and other lifestyle habits (duration of usual sleep, and television or computer viewing). The questionnaire has been used in a longitudinal study in the same areas of Tianjin.21
Children’s body weight was measured with a beam balance scale with participants wearing light indoor clothing without shoes. Body height was measured by a stadiometer. Weight was measured to the nearest 0.1kg and height to the nearest 0.1cm. Body mass index (BMI) was calculated by dividing weight in kilograms by the square of height in meters. Z scores for weight for age, height for age, and weight for length and BMI for age, were calculated based on the standards for the WHO growth reference. 22 Children’s overweight and obesity was defined as a BMI more than or equal to the 85th percentile for age and gender using the WHO BMI growth reference (≥1.035 Z score).22 Z scores for birth weight for gestational age and birth weight for length for gestational age were calculated using our own study population means and standard deviation (n=57,454) in 2009–2011.23 A large-for-gestational-age infant was defined as an infant having a standardized birth weight >90th percentile, whereas a small-for-gestational-age infant was defined as an infant having a standardized birth weight <10th percentile. Macrosomia was defined as birth weight ≥4000 grams. Gestational weight gain was classified according to the Chinese maternal pre-pregnancy BMI classification standard and the 2009 IOM GWG recommendations.24
Statistical analyses
The general characteristics of GDM mothers with and without a history of self-reported hypertensive disorders of pregnancy and their children were compared using T test and chi-square test. General Linear Models were used to compare the difference in Z scores for birth weight for gestational age and birth weight for length for gestational age, Z scores for weight for age, height for age, weight for height, and BMI for age at the baseline survey (1–5 years of offspring age), and changes in Z scores for weight for age and weight for height from birth the baseline survey between offspring of GDM mothers with and without history of self-reported hypertensive disorders of pregnancy. Logistic regression was used to estimate the odds ratios (ORs) and 95% confidence intervals (95% CIs) of large for gestational age and macrosomia at birth, and childhood overweight and obesity at baseline survey associated with self-reported maternal hypertensive disorders of pregnancy status. We set up three models: Model 1 adjusted for maternal age, family history of hypertension, family history of diabetes, history of GDM treatments, education, income, gestational weeks of birth, smoking, pre-pregnancy BMI, and gestational weight gain, and infant feeding; Model 2 additionally adjusted for birth variables for gestational age Z score; Model 3 adjusted for all variables in model 2 and also adjusted for HbA1c at 26–30 gestational weeks, which was measured from 2006 in 1108 of 1263 women, including 79 women with maternal hypertensive disorders of pregnancy. All statistical analyses were performed with PASW for Windows, version 23.0 (Statistics 23, SPSS, IBM, USA).
Results
Maternal and offspring’s general characteristics were presented in Table 1. Of 1263 GDM mothers, 91 (7.2%) mothers had a history of self-reported hypertensive disorders of pregnancy. GDM mothers with a history of self-reported hypertensive disorders of pregnancy had higher mean values of pre-pregnancy BMI, gestation weight gain, fasting and 2-hour glucose at 26–30 gestational weeks compared with those with normal blood pressure during pregnancy (Table 1).
Table 1.
Self-reported maternal hypertensive disorders of pregnancy
|
P for differences | ||
---|---|---|---|
No | Yes | ||
No. of subjects | 1172 | 91 | |
Maternal characteristics | |||
Age (years) | 32.3 (3.5) | 33.0 (3.6) | 0.108 |
Pre-pregnancy body mass index (kg/m2) | 22.9 (3.2) | 25.1 (3.6) | <0.001 |
Fasting glucose at 26–30 gestational weeks (mmol/l) | 5.3 (0.8) | 5.5 (0.8) | 0.037 |
2-hour glucose at 26–30 gestational weeks (mmol/l) | 9.1 (1.3) | 9.4 (1.3) | 0.035 |
HbA1c at 26–30 gestational weeks (n=1108)a | 5.8 (0.6) | 5.9 (0.6) | 0.073 |
History of gestational diabetes mellitus treatments (%) | 0.079 | ||
Yes | 83.7 | 91.1 | |
No | 16.3 | 8.9 | |
Gestational weight gain | |||
Means (kg) | 16.6 (5.8) | 19.0 (7.0) | 0.002 |
Categories (%)b | <0.001 | ||
Inadequate | 12.8 | 6.6 | |
Adequate | 32.4 | 15.4 | |
Excessive | 54.8 | 78.0 | |
Current smoking (%) | 1.9 | 3.3 | 0.349 |
Education (%) | 0.216 | ||
<13 years | 22.0 | 29.7 | |
13–16 years | 70.4 | 64.8 | |
≥16 years | 7.6 | 5.5 | |
Family income (yuan/month, %) | 0.127 | ||
<5000 | 26.9 | 36.3 | |
5000–8000 | 37.0 | 35.2 | |
≥8000 | 36.1 | 28.6 | |
Family history of hypertension (%) | 49.1 | 54.9 | 0.280 |
Family history of diabetes (%) | 34.2 | 39.2 | 0.369 |
Offspring characteristics | |||
Newborn | |||
Gestational weeks of birth (weeks) | 39.1 (1.5) | 38.6 (1.8) | 0.003 |
Sex (boys %) | 52.3 | 62.6 | 0.057 |
Birth weight (g) | 3540 (517) | 3619 (613) | 0.235 |
Birth recumbent length (cm) | 50.8 (2.0) | 51.1 (2.6) | 0.206 |
At baseline survey of 1–5 years old | |||
Age (months) | 26.8 (10.5) | 28.1 (10.3) | 0.273 |
Weight (kg) | 13.4 (2.8) | 14.6 (3.2) | <0.001 |
Height (cm) | 90.5 (8.4) | 92.2 (8.5) | 0.056 |
Body mass index (kg/m2) | 16.1 (1.5) | 16.9 (1.7) | <0.001 |
Breast feeding (%) | 0.008 | ||
Exclusive breast feeding ≥6 months | 42.1 | 26.4 | |
Exclusive breast feeding <6 months | 2.1 | 1.1 | |
Mixed feeding | 42.2 | 49.5 | |
Exclusive formula feeding | 13.7 | 23.1 |
Data are means (SD) or percentage. T-test and chi-square tests were used to assess the difference between two groups.
HbA1c measurements at 26–30 gestational weeks were available from 2006 among 1108 women including 79 women had maternal hypertensive disorders of pregnancy.
Gestational weight gain categories: Inadequate (1): <12.5 kg (pre-pregnancy BMI <18.5 kg/m2), <11.5 kg (BMI 18.5–23.9 kg/m2), <7 kg (BMI 24.0–27.9 kg/m2), and <5 kg (BMI >28 kg/m2); Adequate (1): 12.5–18 kg (BMI <18.5 kg/m2), 11.5–16 kg (BMI 18.5–23.9 kg/m2), 7–11.5 kg (BMI 24.0–27.9 kg/m2), and 5–9 kg (BMI >28 kg/m2); Excessive (1): >18 kg (BMI <18.5 kg/m2), >16 kg (BMI 18.5–23.9 kg/m2), >11.5 kg (BMI 24.0–27.9 kg/m2), and >9 kg (BMI >28 kg/m2), according to the Chinese maternal pre-pregnancy BMI classification standard and the 2009 IOM GWG recommendations.
Offspring of GDM mothers who were diagnosed with hypertensive disorders during pregnancy had higher mean values of Z scores for birth weight for gestational age and birth weight for length than those of GDM mothers with normal blood pressure during pregnancy (Table 2). Self-reported maternal hypertensive disorders of pregnancy were associated with increased risks of childhood large for gestational age (OR 1.74, 95%CI 1.08–2.79) and macrosomia (OR 2.02, 95%CI 1.23–3.31) at birth.
Table 2.
Maternal hypertensive disorders of pregnancy
|
P for differences | ||
---|---|---|---|
No | Yes | ||
No. of subjects | 1172 | 91 | |
Birth weight for gestational age Z score | 0.38 (0.03) | 0.74 (0.11) | 0.005 |
Birth weight for length for gestational age Z score | 0.34 (0.03) | 0.63 (0.11) | 0.019 |
Preterm delivery (%)a | 4.4 | 7.7 | 0.156 |
Small for gestational age (%)b | 5.0 | 3.2 | 0.444 |
Large for gestational age (%)b | 20.5 | 30.8 | 0.021 |
Macrosomia (%)c | 18.9 | 30.8 | 0.006 |
Odd ratio of large for gestational age b | 1.00 | 1.74 (1.08, 2.79) | 0.022 |
Odd ratio of macrosomiac | 1.00 | 2.02 (1.23, 3.31) | 0.005 |
Data are mean (SE), percentage or odds ratio (95% CI); adjusted for maternal age, family history of hypertension, education, family income, and gestational weeks of birth.
Preterm delivery was defined as gestational weeks of delivery <37 weeks.
Small-for-gestational-age was defined as a standardized birth weight <10th percentile; large-for-gestational-age was defined as a standardized birth weight >90th percentile.
Macrosomia was defined as birth weight ≥4000g
After adjustment for maternal age, family history of hypertension, family history of diabetes, history of GDM treatment, education, income, smoking, gestational weeks of birth, pre-pregnancy BMI, gestational weight gain, and infant feeding, children born to GDM mothers with self-reported hypertensive disorders during pregnancy had higher mean values of Z scores for weight for age, weight for length/height, and body mass index for age at 1–5 years old, and greater changes in Z scores for weight for age, and weight for height from birth to 1–5 years old, compared with those born to mothers with normal blood pressure during pregnancy (Table 3). After additional adjustment for Z score for birth weight for gestational age, or birth weight for length, these associations did not change. Offspring born to GDM mothers with self-reported hypertensive disorders of pregnancy were associated with increased risks of overweight and obesity at 1–5 years old (OR 1.88, 95%CI 1.16–3.04) compared with those born to GDM mothers with normal blood pressure during pregnancy. This association did not change after additional adjustment for maternal HbA1c during 16–30 gestational weeks (n=1108). In addition, the association of maternal hypertensive disorders of pregnancy with the risk of childhood overweight and obesity was the same among children less than 3 years old (OR 1.77, 95%CI 1.04–3.04) and in children of 3–5 years old (OR 4.56, 95%CI 1.26–16.5).
Table 3.
Maternal hypertensive disorders of pregnancy
|
P-value | ||
---|---|---|---|
No | Yes | ||
No. of subjects | 1172 | 91 | |
Weight for age Z score | |||
Model 1a | 0.64 (0.03) | 0.96 (0.10) | 0.002 |
Model 2b | 0.64 (0.03) | 0.94 (0.09) | 0.003 |
Model 3c | 0.64 (0.03) | 0.98 (0.10) | 0.002 |
Length/height for age Z score | |||
Model 1a | 0.79 (0.03) | 0.91 (0.11) | 0.272 |
Model 2b | 0.79 (0.03) | 0.88 (0.10) | 0.388 |
Model 3c | 0.82 (0.03) | 0.89 (0.11) | 0.547 |
Weight for length/height Z score | |||
Model 1a | 0.31 (0.03) | 0.68 (0.11) | 0.001 |
Model 2b | 0.31 (0.03) | 0.67 (0.11) | 0.001 |
Model 3c | 0.30 (0.03) | 0.72 (0.11) | 0.001 |
Body mass index for age Z score | |||
Model 1a | 0.24 (0.03) | 0.60 (0.11) | 0.002 |
Model 2b | 0.24 (0.03) | 0.59 (0.11) | 0.002 |
Model 3c | 0.22 (0.03) | 0.62 (0.11) | 0.001 |
Change in weight for age Z score from birth to 1–5 years old | |||
Model 1a | 0.24 (0.04) | 0.45 (0.14) | 0.125 |
Model 2b | 0.23 (0.03) | 0.54 (0.10) | 0.003 |
Model 3c | 0.25 (0.03) | 0.59 (0.10) | 0.002 |
Change in weight for height Z score from birth to 1–5 years old | |||
Model 1a | −0.04 (0.04) | 0.27 (0.15) | 0.045 |
Model 2b | −0.04 (0.03) | 0.32 (0.11) | 0.001 |
Model 3c | −0.05 (0.03) | 0.37 (0.11) | 0.001 |
Prevalence of overweight/obesity (%)d | |||
Model 1a | 19.0 (0.01) | 31.9 (0.04) | 0.003 |
Model 2b | 19.0 (0.01) | 31.7 (0.04) | 0.004 |
Model 3c | 18.8 (0.01) | 31.2 (0.04) | 0.008 |
Odds ratio of overweight/obesity | |||
Model 1a | 1.00 | 1.90 (1.18, 3.06) | 0.009 |
Model 2b | 1.00 | 1.88 (1.16, 3.04) | 0.010 |
Model 3c | 1.00 | 1.86 (1.10, 3.13) | 0.020 |
Data are mean (SE), percentage or odds ratio (95% confidence interval).
Model 1 was adjusted for maternal age, family history of hypertension, family history of diabetes, history of GDM treatments, education, income, smoking, gestational weeks of birth, pre-pregnancy BMI, weight gain during pregnancy, and infant feeding.
Model 2 was adjusted for all variables in model 1 and also birth weight for gestational age Z score in analyses of weight for age Z score and change in weight for age Z score from birth to 1–5 years old, birth length for gestational age Z score in analyses of length/height for age Z score, birth weight for length Z score in analyses of changes in weight for length/height Z score, body mass index for age Z score and change in weight for height Z score from birth to 1–5 years old and odd ratio of overweight/obesity.
Model 3 was adjusted for all variables in model 2 and also adjusted for HbA1c at 26–30 gestational weeks (n=1108, 79 women had maternal hypertensive disorders of pregnancy).
Overweight and obesity is defined as a body mass index higher than the 85th percentiles for age and gender using the WHO growth reference.
Discussion
The present study indicated that offspring born to GDM mothers with a history of hypertensive disorders of pregnancy had higher risks of large for gestational age and macrosomia at birth, and childhood overweight and obesity at 1–5 years old compared with those born to GDM mothers with normal blood pressure during pregnancy.
Only a few epidemiologic studies have assessed the association between maternal hypertensive disorders of pregnancy and fetal growth, and the results are inconsistent. A US prospective study found that maternal preeclampsia reduced the risk of large for gestational age infants.25 However, another Canadian study indicated that maternal preeclampsia and gestational hypertension were associated with increased risks of both large for gestational age and small for gestational age infants. 26 The present study investigated the association of maternal hypertensive disorders of pregnancy with the growth of offspring of GDM mothers, and found a significant positive association between maternal pregnancy-induced hypertension and the risks of infant large for gestational age and macrosomia at birth.
Few studies have investigated the association between hypertensive disorders of pregnancy and childhood overweight and obesity. A recent meta-analysis has indicated that there was a significant increase in BMI in children aged ≥10 years who born to mothers with preeclampsia compared with those who born to mothers with normal blood pressure, but no difference in BMI was found in the studies that included only children aged <10 years.27 An Australia birth cohort study found that maternal pregnancy-induced hypertension was associated with an increased risk of obesity and high blood pressure in young adult offspring.3 To our knowledge, almost no studies investigated the association of hypertensive disorders of pregnancy of GDM mothers with overweight/obesity risk of their children aged less than 5 years. The present study found that offspring of GDM mothers who were diagnosed with hypertensive disorders of pregnancy had higher mean values of Z scores of weight for age, weight for length and BMI for age at 1–5 years old, and higher mean values of changes in Z scores of weight for age and weight for height from birth to age 1–5 years, as well as a higher risk of childhood overweight and obesity at 1–5 years old than those of GDM mothers without a history of hypertensive disorders of pregnancy. Our findings suggest that maternal pregnancy-induced hypertension in GDM mothers is an important risk factor for childhood overweight at an early age.
Some studies have found a significant positive association between high birth weight and childhood obesity.21, 28 The present study also found that offspring born to GDM mothers with a history of hypertensive disorders of pregnancy had higher risks of large for gestational age and macrosomia at birth, and childhood overweight and obesity at 1–5 years old compared with those born to GDM mothers with normal blood pressure during pregnancy. To control for the potential mediating effect of maternal hypertensive disorders of pregnancy on childhood overweight risk via infant high birth weight or length, we additionally adjusted for birth weight for gestational age Z score, birth length for gestational age Z score, and birth weight for length Z score in the multivariable-adjusted analyses, and found that the positive association between maternal hypertensive disorders of pregnancy and the risk of childhood overweight and obesity at 1–5 years old was independent of fetal growth.
Several studies have indicated that pre-pregnancy overweight and excessive gestational weight gain were associated with offspring’s childhood overweight and obesity among the general population.29, 30 One study from our team has got the same findings in children of GDM mothers.10 In the present study, we found that maternal pre-pregnancy overweight, excessive gestational weight gain and maternal history of hypertensive disorders of pregnancy were all associated with offspring’s overweight and obesity when maternal pre-pregnancy overweight, excessive gestational weight gain and maternal history of hypertensive disorders of pregnancy were entered into the multivariable-adjusted model simultaneously (Model 1 – adjusted for maternal age, family history of hypertension, family history of diabetes, history of GDM treatments, education, income, smoking, gestational weeks of birth, and infant feeding). After additional adjustment for BMI for age Z score in Model 2 and HbA1c at 26–30 gestational weeks in Model 3, we still found that maternal pre-pregnancy BMI and maternal history of hypertensive disorders of pregnancy were associated with offspring’s overweight and obesity. However, there was no association of gestational weight gain with offspring’s overweight and obesity. This might indicate that maternal history of hypertensive disorders of pregnancy and pre-pregnancy BMI were independent risk factors for childhood obesity.
Even though the mechanisms of hypertensive disorders of pregnancy with the risk of childhood overweight and obesity in the offspring are poorly understood, several putative mechanisms may be proposed. Washburn et al31 found that male adolescents born prematurely of women with preeclampsia had higher measurements of adiposity than those born prematurely of normotensive pregnancies, and they speculated that the developmental programming such as the altering of leptin regulation system in the offspring born of women with preeclampsia may be associated with childhood postnatal adiposity. Another Germany study found that obesity-related genes such as leptin were considerably up-regulated in placental tissue of preeclampsia,32 and the increased levels of leptin in cord blood of preterm infants could affect blood pressure and body weight of the offspring.33 Other possible mechanisms included oxidative stress and mitochondrial dysfunction.34 Several studies have shown that maternal preeclamptic pregnancies are associated with oxidative stress in the newborn,35 and oxidative stress and mitochondrial dysfunction are associated with obesity.36–38
Our study has several strengths, including a large number of GDM mother-child pairs, and adjustment for multiple prenatal and perinatal factors in the analyses. However, there were several limitations. First, the maternal hypertensive disorders of pregnancy were based on the self-reported questionnaire which may bring retrospective bias. Nevertheless, validation studies in the United States and England have found good concordance between self-reported hypertensive disorder during pregnancy and clinical records.39 Second, since hypertensive disorders of pregnancy could not be disaggregated into gestational hypertension, preeclampsia, and eclampsia in the present study, we cannot separately investigate the effects of different pathophysiology and severity disorders on the growth of offspring. Additionally, the samples were the offspring of GDM mothers, therefore the findings may not be generalizable to the normal population, and thus more studies are needed to confirm our findings.
Our study demonstrates that offspring born to GDM mothers with a history of hypertensive disorders of pregnancy had higher risks of large for gestational age and macrosomia at birth, and childhood overweight and obesity at 1–5 years old compared with those born to GDM mothers with normal blood pressure during pregnancy.
Summary Table.
What is known about the topic?
Hypertensive disorders of pregnancy as a group of medical complications in pregnancy remain to be a major cause of maternal and infant morbidity and mortality worldwide.
Offspring of women with hypertensive disorders of pregnancy are at increased risk for cardiovascular disease at early adults. Maternal preeclampsia increased the risk of intrauterine growth restriction and low birth weight, which in turn is reported to predispose to central obesity, hypertension, coronary heart disease and insulin resistance.
What this study adds?
Offspring born to GDM mothers with a history of hypertensive disorders of pregnancy had higher risks of large for gestational age and macrosomia at birth.
Compared with offspring born to GDM mothers with normal blood pressure during pregnancy, the risk of childhood overweight and obesity is increasing among children born to GDM mothers with a history of hypertensive disorders of pregnancy.
Acknowledgments
We wish to thank the TGDMPP families who are participating in the study and their families, and the TGDMPP Research Group.
Source of Funding
This study was supported by the Tianjin Women’s and Children’s Health Center, Tianjin Public Health Bureau, European Foundation for the Study of Diabetes (EFSD)/Chinese Diabetes Society (CDS)/Lilly programme for Collaborative Research between China and Europe, and the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health under Award Number R01DK100790.
Abbreviation List
- HDP
Hypertensive disorders of pregnancy
- GDM
Gestational diabetes mellitus
- OR
odds ratios
- OGTT
Oral glucose tolerance test
- IGT
Impaired glucose tolerance
- TGDMPP
Tianjin Gestational Diabetes Mellitus Prevention Program
- BMI
Body mass index
Footnotes
Conflict(s) of Interest/Disclosure Statement
None
References
- 1.Vest AR, Cho LS. Hypertension in pregnancy. Cardiology clinics. 2012;30(3):407–423. doi: 10.1016/j.ccl.2012.04.005. [DOI] [PubMed] [Google Scholar]
- 2.Kajantie E, Eriksson JG, Osmond C, Thornburg K, Barker DJ. Pre-eclampsia is associated with increased risk of stroke in the adult offspring: the Helsinki birth cohort study. Stroke; a journal of cerebral circulation. 2009;40(4):1176–80. doi: 10.1161/STROKEAHA.108.538025. [DOI] [PubMed] [Google Scholar]
- 3.Davis EF, Lewandowski AJ, Aye C, Williamson W, Boardman H, Huang RC, et al. Clinical cardiovascular risk during young adulthood in offspring of hypertensive pregnancies: insights from a 20-year prospective follow-up birth cohort. BMJ Open. 2015;5(6):e008136. doi: 10.1136/bmjopen-2015-008136. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Lewandowski AJ, Davis EF, Yu G, Digby JE, Boardman H, Whitworth P, et al. Elevated blood pressure in preterm-born offspring associates with a distinct antiangiogenic state and microvascular abnormalities in adult life. Hypertension. 2015;65(3):607–614. doi: 10.1161/HYPERTENSIONAHA.114.04662. [DOI] [PubMed] [Google Scholar]
- 5.Xiong X, Mayes D, Demianczuk N, Olson DM, Davidge ST, Newburn-Cook C, et al. Impact of pregnancy-induced hypertension on fetal growth. American journal of obstetrics and gynecology. 1999;180(1):207–213. doi: 10.1016/s0002-9378(99)70176-6. [DOI] [PubMed] [Google Scholar]
- 6.Leger J, Levy-Marchal C, Bloch J, Pinet A, Chevenne D, Porquet D, et al. Reduced final height and indications for insulin resistance in 20 year olds born small for gestational age: regional cohort study. Bmj. 1997;315(7104):341–347. doi: 10.1136/bmj.315.7104.341. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Leon DA, Lithell HO, Vågerö D, Koupilová I, Mohsen R, Berglund L, et al. Reduced fetal growth rate and increased risk of death from ischaemic heart disease: cohort study of 15 000 Swedish men and women born 1915–29. Bmj. 1998;317(7153):241–245. doi: 10.1136/bmj.317.7153.241. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Association AD. Diagnosis and classification of diabetes mellitus. Diabetes care. 2010;33(Supplement 1):S62–S69. doi: 10.2337/dc10-S062. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Hunt KJ, Schuller KL. The Increasing Prevalence of Diabetes in Pregnancy. Obstetrics and gynecology clinics of North America. 2007;34(2):173–vii. doi: 10.1016/j.ogc.2007.03.00. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Leng J, Li W, Zhang S, Liu H, Wang L, Liu G, et al. GDM Women’s Pre-Pregnancy Overweight/Obesity and Gestational Weight Gain on Offspring Overweight Status. PloS one. 2015;10(6):e0129536. doi: 10.1371/journal.pone.0129536. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Zhang F, Dong L, Zhang C, Li B, Wen J, Gao W, et al. Increasing prevalence of gestational diabetes mellitus in Chinese women from 1999 to 2008. Diabetic Medicine. 2011;28(6):652–657. doi: 10.1111/j.1464-5491.2010.03205.x. [DOI] [PubMed] [Google Scholar]
- 12.Dabelea D. The predisposition to obesity and diabetes in offspring of diabetic mothers. Diabetes care. 2007;30(Suppl 2):S169–74. doi: 10.2337/dc07-s211. [DOI] [PubMed] [Google Scholar]
- 13.Bryson CL, Ioannou GN, Rulyak SJ, Critchlow C. Association between gestational diabetes and pregnancy-induced hypertension. American journal of epidemiology. 2003;158(12):1148–1153. doi: 10.1093/aje/kwg273. [DOI] [PubMed] [Google Scholar]
- 14.Zhang S, Liu H, Zhang C, Wang L, Li N, Leng J, et al. Maternal glucose during pregnancy and after delivery in women with gestational diabetes mellitus on overweight status of their children. Biomed Res Int. 2015;2015:543038. doi: 10.1155/2015/543038. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Hu G, Tian H, Zhang F, Liu H, Zhang C, Zhang S, et al. Tianjin Gestational Diabetes Mellitus Prevention Program: study design, methods, and 1-year interim report on the feasibility of lifestyle intervention program. Diabetes research and clinical practice. 2012;98(3):508–17. doi: 10.1016/j.diabres.2012.09.015. [DOI] [PubMed] [Google Scholar]
- 16.Li W, Zhang S, Liu H, Wang L, Zhang C, Leng J, et al. Different associations of diabetes with beta-cell dysfunction and insulin resistance among obese and nonobese Chinese women with prior gestational diabetes mellitus. Diabetes care. 2014;37(9):2533–9. doi: 10.2337/dc14-0573. [DOI] [PubMed] [Google Scholar]
- 17.Liu H, Zhang C, Zhang S, Wang L, Leng J, Liu D, et al. Prepregnancy body mass index and weight change on postpartum diabetes risk among gestational diabetes women. Obesity (Silver Spring) 2014;22(6):1560–7. doi: 10.1002/oby.20722. [DOI] [PubMed] [Google Scholar]
- 18.Wang L, Liu H, Zhang S, Leng J, Liu G, Zhang C, et al. Obesity index and the risk of diabetes among Chinese women with prior gestational diabetes. Diabetic medicine : a journal of the British Diabetic Association. 2014;31(11):1368–77. doi: 10.1111/dme.12532. [DOI] [PubMed] [Google Scholar]
- 19.Li YP, He YN, Zhai FY, Yang XG, Hu XQ, Zhao WH, et al. Comparison of assessment of food intakes by using 3 dietary survey methods. Zhonghua Yu Fang Yi Xue Za Zhi. 2006;40(4):273–80. [PubMed] [Google Scholar]
- 20.Yuan X, Liu H, Wang L, Zhang S, Zhang C, Leng J, et al. Gestational hypertension and chronic hypertension on the risk of diabetes among gestational diabetes women. Journal of diabetes and its complications. 2016;30(7):1269–74. doi: 10.1016/j.jdiacomp.2016.04.025. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Zhang X, Liu E, Tian Z, Wang W, Ye T, Liu G, et al. High birth weight and overweight or obesity among Chinese children 3–6 years old. Preventive medicine. 2009;49(2–3):172–8. doi: 10.1016/j.ypmed.2009.07.013. [DOI] [PubMed] [Google Scholar]
- 22.van Emmerik NM, Renders CM, van de Veer M, van Buuren S, van der Baan-Slootweg OH, Kist-van Holthe JE, et al. High cardiovascular risk in severely obese young children and adolescents. Archives of disease in childhood. 2012;97(9):818–21. doi: 10.1136/archdischild-2012-301877. [DOI] [PubMed] [Google Scholar]
- 23.Li N, Liu E, Guo J, Pan L, Li B, Wang P, et al. Maternal prepregnancy body mass index and gestational weight gain on offspring overweight in early infancy. PloS one. 2013;8(10):e77809. doi: 10.1371/journal.pone.0077809. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Yaktine AL, Rasmussen KM. Weight Gain During Pregnancy:: Reexamining the Guidelines. National Academies Press; 2009. [PubMed] [Google Scholar]
- 25.Powe CE, Ecker J, Rana S, Wang A, Ankers E, Ye J, et al. Preeclampsia and the risk of large-for-gestational-age infants. American journal of obstetrics and gynecology. 2011;204(5):425. e1–425. e6. doi: 10.1016/j.ajog.2010.12.030. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Xiong X, Demianczuk NN, Saunders LD, Wang FL, Fraser WD. Impact of preeclampsia and gestational hypertension on birth weight by gestational age. American journal of epidemiology. 2002;155(3):203–9. doi: 10.1093/aje/155.3.203. [DOI] [PubMed] [Google Scholar]
- 27.Davis EF, Lazdam M, Lewandowski AJ, Worton SA, Kelly B, Kenworthy Y, et al. Cardiovascular risk factors in children and young adults born to preeclamptic pregnancies: a systematic review. Pediatrics. 2012;129(6):e1552–61. doi: 10.1542/peds.2011-3093. [DOI] [PubMed] [Google Scholar]
- 28.Qiao Y, Ma J, Wang Y, Li W, Katzmarzyk PT, Chaput J-P, et al. Birth weight and childhood obesity: a 12-country study. International Journal of Obesity Supplements. 2015;5:S74–S79. doi: 10.1038/ijosup.2015.23. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Nohr EA, Vaeth M, Baker JL, Sorensen T, Olsen J, Rasmussen KM. Combined associations of prepregnancy body mass index and gestational weight gain with the outcome of pregnancy. The American journal of clinical nutrition. 2008;87(6):1750–9. doi: 10.1093/ajcn/87.6.1750. [DOI] [PubMed] [Google Scholar]
- 30.Young TK, Woodmansee B. Factors that are associated with cesarean delivery in a large private practice: the importance of prepregnancy body mass index and weight gain. Am J Obstet Gynecol. 2002;187(2):312–8. doi: 10.1067/mob.2002.126200. discussion 318–20. [DOI] [PubMed] [Google Scholar]
- 31.Washburn L, Nixon P, Russell G, Snively BM, O’Shea TM. Adiposity in adolescent offspring born prematurely to mothers with preeclampsia. The Journal of pediatrics. 2013;162(5):912–917. e1. doi: 10.1016/j.jpeds.2012.10.044. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Reimer T, Koczan D, Gerber B, Richter D, Thiesen H, Friese K. Microarray analysis of differentially expressed genes in placental tissue of pre-eclampsia: up-regulation of obesity-related genes. Molecular human reproduction. 2002;8(7):674–680. doi: 10.1093/molehr/8.7.674. [DOI] [PubMed] [Google Scholar]
- 33.Hytinantti T, Koistinen HA, Koivisto VA, Karonen SL, Rutanen EM, Andersson S. Increased leptin concentration in preterm infants of pre-eclamptic mothers. Archives of disease in childhood Fetal and neonatal edition. 2000;83(1):F13–6. doi: 10.1136/fn.83.1.F13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Simmons RA. Preeclampsia and Prematurity as Precursors to Adolescent Obesity. The Journal of pediatrics. 2013;162(5):889. doi: 10.1016/j.jpeds.2013.01.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Chamy VM, Lepe J, Catalan A, Retamal D, Escobar JA, Madrid EM. Oxidative stress is closely related to clinical severity of pre-eclampsia. Biological research. 2006;39(2):229–236. doi: 10.4067/s0716-97602006000200005. [DOI] [PubMed] [Google Scholar]
- 36.Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. The Journal of clinical investigation. 2004;114(12):1752–1761. doi: 10.1172/JCI21625. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Rogge MM. The role of impaired mitochondrial lipid oxidation in obesity. Biol Res Nurs. 2009;10(4):356–73. doi: 10.1177/1099800408329408. [DOI] [PubMed] [Google Scholar]
- 38.Bondia-Pons I, Ryan L, Martinez JA. Oxidative stress and inflammation interactions in human obesity. Journal of physiology and biochemistry. 2012;68(4):701–711. doi: 10.1007/s13105-012-0154-2. [DOI] [PubMed] [Google Scholar]
- 39.Dietz P, Bombard J, Mulready-Ward C, Gauthier J, Sackoff J, Brozicevic P, et al. Validation of self-reported maternal and infant health indicators in the Pregnancy Risk Assessment Monitoring System. Maternal and child health journal. 2014;18(10):2489–98. doi: 10.1007/s10995-014-1487-y. [DOI] [PMC free article] [PubMed] [Google Scholar]